Supportive care: Economic considerations in advanced kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 11, Issue 10, 2016, Pages 1915-1920

  Morton, Rachael L ^a   Tamura, Manjula Kurella ^b   Coast, Joanna ^c   Davison, Sara N ^d  

^a UNIVERSITY OF SYDNEY   (Australia)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Chronic; Conservative care; Cost benefit analysis; Health economics; Humans; Palliative care; Personal satisfaction; Prospective studies; Quality of life; Quality adjusted life years; Renal dialysis; Renal insufficiency; Supportive care

Indexed keywords

ANALGESIA; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DISTRESS SYNDROME; FUNCTIONAL STATUS; HEALTH ECONOMICS; HEMODIALYSIS; HOSPICE CARE; HUMAN; KIDNEY FAILURE; LOW INCOME COUNTRY; MEDICARE; MIDDLE INCOME COUNTRY; PALLIATIVE THERAPY; PATIENT CARE PLANNING; PATIENT-REPORTED OUTCOME; PHYSICAL WELL-BEING; PROSPECTIVE STUDY; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESOURCE ALLOCATION; REVIEW; SATISFACTION; TERMINAL CARE; CHRONIC KIDNEY FAILURE; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE COST; HEALTH STATUS; PATIENT PREFERENCE;

COST-BENEFIT ANALYSIS; HEALTH CARE COSTS; HEALTH STATUS; HUMANS; KIDNEY FAILURE, CHRONIC; PATIENT PREFERENCE; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; TERMINAL CARE;

EID: 85021404604     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.12651115     Document Type: Review

References (56)

1. United States Renal Data System: Medicare Expenditures for Persons with ESRD. 2015 USRDS Annual Data Report: Epidemiology of Kidney Disease in the United States, Bethesda, MD, National Institute of Diabetes and Digestive and Kidney Diseases, 2015
2. Wong SP, Kreuter W, Curtis JR, Hall YN, O’Hare AM: Trends in in-hospital cardiopulmonary resuscitation and survival in adults receiving maintenance dialysis. JAMA Intern Med 175: 1028-1035, 2015
3. Wyld M, Morton RL, Hayen A, Howard K, Webster AC: A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. PLoS Med 9: e1001307, 2012
4. Wong SP, Kreuter W, O’Hare AM: Treatment intensity at the end of life in older adults receiving long-term dialysis. Arch Intern Med 172: 661-663, 2012
5. Brown MA, Collett GK, Josland EA, Foote C, Li Q, Brennan FP: CKD in elderly patients managed without dialysis: Survival, symptoms, and quality of life. Clin J Am Soc Nephrol 10: 260-268, 2015
6. Schwartz CE, Merriman MP, Reed GW, Hammes BJ: Measuring patient treatment preferences in end-of-life care research: Applications for advance care planning interventions and response shift research. J Palliat Med 7: 233-245, 2004
7. Davison SN, Levin A, Moss AH, Jha V, Brown EA, Brennan F, Murtagh FE, Naicker S, Germain MJ, O’Donoghue DJ, Morton RL, Obrador GT: Executive summary of the KDIGOControversies Conference on Supportive Care in Chronic Kidney Disease: Developing a roadmap to improving quality care. Kidney Int 88: 447-459, 2015
8. Davison SN, Jassal SV: Supportive care: Integration of patientcentered kidney care to manage symptoms and geriatric syndromes. Clin J Am Soc Nephrol 11: 1882-1891, 2016
9. Brown EA, Bekker HL, Davison SN, Koffman J, Schell JO: Supportive care: Communication strategies to improve cultural competence in shared decision making. Clin J Am Soc Nephrol 11: 1902-1908, 2016
10. Murtagh FEM, Burns A, Moranne O, Morton RL, Naicker S: Supportive care: Comprehensive conservative care in end-stage kidney disease. Clin J Am Soc Nephrol 11: 1909-1914, 2016
11. NHS Scotland: Renal disease in the last days of life: Scottish Palliative Care Guidelines, 2009. Available at: http://www.palliativecareguidelines.scot.nhs.uk/guidelines/end-of-life-care/renal-disease-in-the-last-days-of-life.aspx. Accessed May 18, 2016
12. Brown MA, Crail SM, Masterson R, Foote C, Robins J, Katz I, Josland E, Brennan F, Stallworthy EJ, Brennan F, Siva B, Crail S, Brennan F, Siva B, Brennan F, Brown M, Miller C, Urban AK, Sajiv C, Stallworthy EJ, Glavish RN, May S, Langham R, Walker R, Fassett RG, Morton RL, Crail SM, Stewart C, Brennan F, Phipps L, Walker R, Healy H, Berquier I, Crail SM; Australian and New Zealand Society of Nephrology: ANZSN renal supportive care 2013: Opinion pieces [corrected]. Nephrology (Carlton) 18: 401-454, 2013
13. Renal Physicians Association: Clinical Practice Guideline, Shared Decision-Making in the Appropriate Initiation of and Withdrawal from Dialysis, 2nd Ed., Rockville, MD, 2010
14. Douglas C, Murtagh FE, Chambers EJ, Howse M, Ellershaw J: Symptommanagement for the adult patient dying with advanced chronic kidney disease: A review of the literature and development of evidence-based guidelines by a United Kingdom Expert Consensus Group. Palliat Med 23: 103-110, 2009
15. Murray AM, Arko C, Chen SC, Gilbertson DT, Moss AH: Use of hospice in the United States dialysis population. Clin J Am Soc Nephrol 1: 1248-1255, 2006
16. Morrison RS, Penrod JD, Cassel JB, Caust-Ellenbogen M, Litke A, Spragens L, Meier DE; Palliative Care Leadership Centers’ Outcomes Group: Cost savings associatedwithUS hospital palliative care consultation programs. Arch Intern Med 168: 1783-1790, 2008
17. Gray AC, Clarke P, Wolstenholme JL, Wordsworth S: Applied Methods of Cost-Effectiveness Analysis in Health Care, Oxford, United Kingdom, Oxford University Press, 2011
18. Lee CP, Chertow GM, Zenios SA: A simulation model to estimate the cost and effectiveness of alternative dialysis initiation strategies. Med Decis Making 26: 535-549, 2006
19. Lee CP, Chertow GM, Zenios SA: An empiric estimate of the value of life: Updating the renal dialysis cost-effectiveness standard. Value Health 12: 80-87, 2009
20. Gorodetskaya I, Zenios S, McCulloch CE, Bostrom A, Hsu CY, Bindman AB, Go AS, Chertow GM: Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int 68: 2801-2808, 2005
21. Teerawattananon Y, Mugford M, Tangcharoensathien V: Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: Evidence for coverage decisions in Thailand. Value Health 10: 61-72, 2007
22. Davidson SN, Murtagh FE, Higginson IJ: Methodological considerations for end-of-life research in patients with chronic kidney disease. J Nephrol 21: 268-282, 2008
23. Guinness L, Wiseman V: Introduction to Health Economics, 2nd Ed., London, Open University Press, 2011
24. Chandna SM, Da Silva-Gane M, Marshall C, Warwicker P, Greenwood RN, Farrington K: Survival of elderly patientswith stage 5 CKD: Comparison of conservative management and renal replacement therapy. Nephrol Dial Transplant 26: 1608-1614, 2011
25. Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE: Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant 22: 1955-1962, 2007
26. Wong CF, McCarthy M, Howse ML, Williams PS: Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis. Ren Fail 29: 653-659, 2007
27. Carson RC, Juszczak M, Davenport A, Burns A: Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? Clin J Am Soc Nephrol 4: 1611-1619, 2009
28. Coast J, Flynn T, Sutton E, Al-Janabi H, Vosper J, Lavender S, Louviere J, Peters T: Investigating Choice Experiments for Preferences of Older People (ICEPOP): Evaluative spaces in health economics. J Health Serv Res Policy 13[Suppl 3]: 31-37, 2008
29. Morton RL, Snelling P, Webster AC, Rose J, Masterson R, Johnson DW, Howard K: Factors influencing patient choice of dialysis versus conservative care to treat end-stage kidney disease. CMAJ 184: E277-E283, 2012
30. Sutton EJ, Coast J: Development of a supportive care measure for economic evaluation of end-of-life care using qualitative methods. Palliat Med 28: 151-157, 2014
31. Hussain JA, Mooney A, Russon L: Comparison of survival analysis and palliative care involvement in patients aged over 70 years choosing conservative management or renal replacement therapy in advanced chronic kidney disease. Palliat Med 27: 829-839, 2013
32. Chambers EJ, Germain M, Brown EA: Supportive Care for the Renal Patient, 2nd Ed., Oxford, United Kingdom, Oxford University Press, 2010
33. Smith S, Brick A, O’Hara S, Normand C: Evidence on the cost and cost-effectiveness of palliative care: A literature review. Palliat Med 28: 130-150, 2014
34. Gomes B, Harding R, Foley KM, Higginson IJ: Optimal approaches to the health economics of palliative care: Report of an international think tank. J Pain Symptom Manage 38: 4-10, 2009
35. Al-Janabi H, van Excel J, Brouwer W, Coast J: A framework for including family health spillovers in economic evaluation. Med Decis Making 36: 176-186, 2016
36. McIntosh E: Applied Methods of Cost-Benefit Analysis in Health Care, Oxford, Oxford University Press, 2010
37. Coast J: Strategies for the economic evaluation of end-of-life care: Making a case for the capability approach. Expert Rev Pharmacoecon Outcomes Res 14: 473-482, 2014
38. Coast J, Smith R, Lorgelly P: Should the capability approach be applied in health economics? Health Econ 17: 667-670, 2008
39. Alston H: Conservative care for end-stage kidney disease: Joint medical conference with the Renal Association, British Geriatrics Society and Association for Palliative Medicine. Clin Med (Lond) 13: 383-386, 2013
40. Wish JB: The role of 30-day readmission as a measure of quality. Clin J Am Soc Nephrol 9: 440-442, 2014
41. Gomes B, Calanzani N, Curiale V, McCrone P, Higginson IJ: Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers. Cochrane Database Syst Rev 6: CD007760, 2013
42. Morton RL, Tong A, Howard K, Snelling P, Webster AC: The views of patients and carers in treatment decision making for chronic kidney disease: Systematic review and thematic synthesis of qualitative studies. BMJ 340: c112, 2010
43. Reuben DBTM, Tinetti ME: Goal-oriented patient care-an alternative health outcomes paradigm. N Engl J Med 366: 777-779, 2012
44. Billingham LJ, Abrams KR, Jones DR: Methods for the analysis of quality-of-life and survival data in health technology assessment. Health Technol Assess 3: 1-152, 1999
45. Kreif N, Grieve R, Radice R, Sadique Z, Ramsahai R, Sekhon JS: Methods for estimating subgroup effects in cost-effectiveness analyses that use observational data. Med Decis Making 32: 750-763, 2012
46. Drummond M, Sculpher MJ, Torrance GW, O’Brien B, Stoddardt GL: Methods for the Economic Evaluation of Health Care Programmes, Oxford,United Kingdom,Oxford University Press, 2005
47. White SL, Chadban SJ, Jan S, Chapman JR, Cass A: How can we achieve global equity in provision of renal replacement therapy? Bull World Health Organ 86: 229-237, 2008
48. Moosa MR, Kidd M: The dangers of rationing dialysis treatment: The dilemma facing a developing country. Kidney Int 70: 1107-1114, 2006
49. Couser WG, Remuzzi G, Mendis S, Tonelli M: The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 80: 1258-1270, 2011
50. Klarenbach SW, Tonelli M, Chui B, Manns BJ: Economic evaluation of dialysis therapies. Nat Rev Nephrol 10: 644-652, 2014
51. Luckett T, Spencer L, Morton RL, Pollock CA, Lam L, Silvester W, Sellars M, Detering KM, Butow PN, Tong A, Clayton JM: Advance care planning in chronic kidney disease: A survey of current practice in Australia [published online ahead of print February 10, 2016]. Nephrology (Carlton) doi:10.1111/nep.1274
52. United Kingdom Government: Hospital episode statistics. In: Health and Social Care Information Centre (HSCIC), Leeds, United Kingdom, United Kingdom Government, 2013
53. United States Renal Data System: USRDS Special Study Center (SSC) on Palliative and End-of-Life Care, Bethesda, MD, United States. 2015
54. Grewal I, Lewis J, Flynn T, Brown J, Bond J, Coast J: Developing attributes for a generic quality of life measure for older people: Preferences or capabilities? Soc Sci Med 62: 1891-1901, 2006
55. Coast J, Flynn TN, Natarajan L, Sproston K, Lewis J, Louviere JJ, Peters TJ: Valuing the ICECAP capability index for older people. Soc Sci Med 67: 874-882, 2008
56. Oakley A, Strange V, Bonell C, Allen E, Stephenson J; RIPPLE Study Team: Process evaluation in randomised controlled trials of complex interventions. BMJ 332: 413-416, 2006